Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corticoid Infiltration for Chronic Lumbago with Neo-articulation
NCT01206699Phase 4Terminated
- Sponsor
- CHU de Nantes
- Start
- Sep 2010
- Primary completion
- Feb 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of cortivazol in low back pain (LBP) (2 arms), sponsored by CHU de Nantes. Primary endpoint: Difference between mean pain during latest 24 hours preceding infiltration and mean pain preceding visit S4 at 4 weeks. Started Sep 2010; status: terminated.
02
Drugs
cortivazol
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT01206699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01206699.